Skip to main content

Table 1 Patient characteristics

From: Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas

 

Diffuse astrocytoma

Anaplastic astrocytoma

Glioblastoma

Patients (n)

23

14

74

Age

 Mean

45.0

52.2

61.4

 Range

2.6–78.5

29.9–77.3

21.2–78.4

Sex (n)

 Male

15

8

48

 Female

8

6

26

Status (n)

 Alive

4

0

1

 Dead

19

14

73

Over survival (months)

 Median

57.1

18.4

8.4

 Range

3.4–267.0

2.1–48.3

0.08–163.5

IDH statusa

 Mutated

14

4

2

 Wildtype

9

10

72

  1. aIDH status was only investigated by immunohistochemistry for glioblastoma patients. For patients diagnosed with diffuse and anaplastic astrocytoma, IDH status was investigated by immunohistochemistry and next generation sequencing (See Materials and Methods section: Immunohistochemistry)
  2. Abbreviations: IDH isocitrate dehydrogenase
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us